Peer Review History
| Original SubmissionDecember 31, 2020 |
|---|
|
PONE-D-20-40795 Impact of different frequencies of controlled breath and pressure-support levels during biphasic positive airway pressure ventilation on the lung and diaphragm in experimental mild acute respiratory distress syndrome PLOS ONE Dear Dr. Rocco, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please note that relevant criticism was raised regarding the methodology of the presented experiments: a bias in that area is a reason for rejection due to Plos One standards. Therefore, please carefully respond to all the comments prensented by the reviewers. Regarding the presented results, the strongest signal appears related to the bipap50-psv50 group. Looking at the difference in table 1, 8 breaths were at pHigh in the bipap50-psv50 group (no breaths at plow: why?), while 9 breaths at pLow for the bipap50-psv100 group (no breaths at phigh: why?). A different respiratory pattern could be the reason leading to sili? Why the psv 50 rats breathe at pHigh and the psv100 at pLow? Another point that needs to be clarified is the peak transpulmonary pressure: the bipap50-psv50 group showed 22 at pHigh vs.15 in the bipap50-psv0 group; how do you explain? I expect that it should be the same. Is it possible that 22 is due to PSV over the pHigh (although, based on the methods section, that should not be the case: pHigh sholud refer to the spontaneous non PSV breaths at cpapHigh). If not, did you discriminate if PSV breaths occurred at pLow vs. pHigh? A triggered PSV cycle above pHigh might lead to overdistention and stretch, possibly explaining some of your results. Please submit your revised manuscript by Apr 11 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Andrea Coppadoro Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please provide the source of the animals used in your study. 3. In order to meet our data availability and reproducibility criteria, please provide your custom-made software written in LabVIEW and your routine written in MATLAB for data analysis. You may either provide copies of the code as supplementary files, or you can provide a link to a permanent URL. 4. Thank you for stating the following financial disclosure: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." At this time, please address the following queries:
Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 5. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: COMMENTS TO AUTHORS The authors hypothesized that lung and diaphragm injury may be altered by levels of pressure support and frequency of controlled-mechanical breath during Bilevel ventilation. By using mild lung injury model, the authors found that 1) lung injury was less when spontaneous effort was facilitated by decreasing mandatory mechanical breath during Bilevel ventilation; 2) but lung injury was deteriorated when spontaneous effort assisted by pressure support occurred on a top of Phigh level. The reviewer found that the current study was intriguing and covered a hot topics regarding how physicians facilitated spontaneous breathing in lung injury. But on the other hand, it was difficult to grasp what the main message was from the current version of manuscript due to numbers of groups. # message The reviewer thinks the current study has two messages; first, lung injury was decreased when spontaneous effort was facilitated during Plow by decreasing mandatory mechanical breath during Bilevel ventilation (BIVENT100+PS0 vs. BIVENT50+PS0), second, lung injury was deteriorated if ventilatory settings were manipulated to promote spontaneous effort assisted by pressure support on a top of Phigh level (BIVENT50+PS50). Especially 2nd message is important and should be stressed in a text. Thus, the reviewer suggests the authors to clarify this in conclusion and discussion, in order to let the message more straightforward. Supplemental figure-1 showing sample waveforms indeed helps readers to grasp the message so that this should be implemented in main text. # potential mechanism What was surprising to me is that PS-assisted spontaneous effort was observed only 8/mins on a top of Phigh (BIVENT50+PS50), but injury was significantly different from others. How was that possible by such a low respiratory rate occurring during Phigh? Reviewer #2: In this study, Thompson et al evaluated the lung and diaphragm injury in an experimental model of E.coli induced ARDS, followed by different BIVENT. The authors stated that the frequency of controlled breaths and the PSV level during BIVENT can affect lung and diaphragm damage. In my opinion this is a very interesting study, that could help to test different mechanical ventilation strategies in ARDS patients. The present study is well planned and well written. For these reasons I have only minor comments - In the results, there is no mention about the mortality of the animals, during the 24 hours after E.coli administration. Is it possible to add this aspect? - Among the experimental groups the authors did not consider a group of rat only mechanically ventilated without LPS insult. Please explain the reason of this choice. - I have only a doubt regarding the time of ventilation. I think (looking to available literature) that only 1 hour of mechanical ventilation is not sufficient to induce a diaphragm injury and a structural disorganization. Please hypothesize a possible explanation about this aspect. - No differences in terms of oxygenation were found among the experimental groups. Was this result expected? - In the text, the BIVENT-50-PSV100% was not deeply analyzed. In the Discussion, in “Comparisons across the BIVENT-50 groups” section, the focus was about the comparison between PSV0 versus PSV50. The authors could give more attention on PSV100 results and comparisons versus the other group, since the BIVENT-50-PSV100 seems to be the most promising ventilation method. Reviewer #3: Thompson AF. et al. reported the effect of Bilevel at 2 set up of RR and with or without PS (i.e. BILEVEL 50) on macroscopic and microscopic variables of lung and diaphragm injury in a preclinical investigation using a rodent model of lung injury by IT instillation of E. Coli LPS. The primary aim of the study is based on a sample size justified to evaluate the difference in alveolar collapse (i.e. 1 of the 3 items used to estimate DAD) among Bilevel settings using a higher or a lower fixed RR (i.e. 100 versus 50, respectively) and with no PS. The authors further evaluate the presence of differences on the respiratory parameters only in the lower RR group of BILEVEL (i.e. 50 bpm) according to different levels of PS. Although the work is of potential clinical interest at bedside, I think that some bias exists in both the animal model and in the interpretation of the study results that does not clearly stick to the study findings. 1. At first, the authors refer to an animal model of mild ARDS. I am not sure that this is correct. According to the criteria of Berlin, PEEP must be included to characterize the severity of ARDS – at the “initial time point” the authors state that PF was lower of 300 in all groups – however, as reported in the methods section – PEEP was 0 at baseline before randomization – this does not guarantee that levels of PF are below 300 in the presence of some level of PEEP at baseline. Furthermore, 1 h of ventilation with PEEP=5 cmH2O brings the PF ratio up to an average value way above 300 (FINAL timepoint) in all groups – and this further confirms that the definition of ARDS is not accurate. Data of gas exchange at baseline should be reported. 2. Quantification of TV of 6 mL/Kg – I have a similar thought as previously observed -considering that the quantification of a TV = 6 ml/kg would report a different driving pressure at ZEEP compared to a DP estimated at a level of PEEP=5 cmH2O – this suggests that the levels of PSV used after randomization to achieve 6 mL/kg was based on an estimation of DP performed at ZEEP and not at PEEP=5 – I expect a different DP for the same TV at ZEEP versus PEEP 5 because of a different position on the PV curve. The authors should report average levels of PSV used in the different groups and the average level of Phigh of the BILEVEL in all groups. 3. It is not clear what the authors mean about the following sentence: “Flow trigger sensitivity was adjusted for adequate inspiratory effort, according to esophageal pressure (Pes) decay”? Did the authors use a fixed flow trigger in all the PSV experiments, didn’t they? The use of different thresholds of flow trigger may make unreliable the study findings as it means that this variable was not kept the same among different PSV experiments. 4. Furthermore, the different PSV groups showed a total RR – despite not significantly different I assume because of the low sample size among the groups - ranging from an average of 81 (PSV 50%) to 113 bpm (PSV 100%) with an increasing level of PSV – which is kind of counterintuitive…I can’t buy for what I see this U-shaped concept.. As first, I would ask whether the level of sedation was kept constant among the different PSV steps or not as in a study previously published by the same investigators (doi.org/10.1371/journal.pone.0246891). Actually, I would expect a lower RR in the PSV100% group in the absence of brain injury.. Furthermore, this makes me uncomfortable about the calculation of the pressure–time product per minute (PTPmin) that was calculated as the integral of ΔPes over one minute – this is, certainly, affected by a different RR among the study groups – so I am not sure if the difference among groups in PTP is because of the animal respiratory effort or because of the different RR. Looking at the PTP of the 2 groups on BILEVEL 100 versus 50 and no PSV – it seems unlikely that the PTP in the BILEVEL 50 and no PSV does not differ compared to the BILEVEL 100 and no PSV in the presence of a 50% decrease of fixed breaths. Levels of Pes should be reported among the study groups. 5. Variability of Vt is quite harsh to interpret as at PSV0% versus PSV 100% CV of TV is basically the same 6. About the DAD score, I am not sure to understand such lower levels of edema and collapse (i.e. media of 2) and a median of 5 for overdistension in the presence of quite low levels of mean lung pressure (i.e. mean value of 4.1) in the PSV100% BILEVEL50 7. Significance was established at p<0.05 – was a two-sided p-value, is it correct? Please add this information. 8. Table 1: Airlow > typo, change it into airflow 9. Discussion: “Therefore, there is a certain threshold of PSV in BIVENT-50 that may yield a continuous excessive stress.” It is a speculation please remove it – the study wasn’t powered to assess a difference in stress among the groups - stress was not the primary study aim – furthermore the data in BILEVEL 50 PSV 50% shows a higher Pmean,L - although not significant compared to other groups - a lower variation of TV and a lower RR. However, in figure 2, despite a pretty low RR in BILEVEL 50 PSV 50%, the swings of Pes were quite limited compared to PSV0% and even PSV100% - this is quite a surprise to me looking at the PTP - again any difference in the assisted flow trigger or sedation? ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Impact of different frequencies of controlled breath and pressure-support levels during biphasic positive airway pressure ventilation on the lung and diaphragm in experimental mild acute respiratory distress syndrome PONE-D-20-40795R1 Dear Dr. Rocco, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Andrea Coppadoro Academic Editor PLOS ONE Additional Editor Comments: PLEASE CORRECT A TYPO IN THE ABSTRACT, FIRST LINE OF THE RESULTS, should read : bivent 50+psv0, compared to bivent 100 psv0, reduced... Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed Reviewer #3: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: I think that this study is very interesting. The authors answered completely all my questions. For these reason my suggestion is to accept this article. Reviewer #3: I congratulate with the authors on the work provided during the revision process. I am satisfied with the responses provided by the authors. I just recommend to the authors to upload the images of the manuscript using a higher quality resolution as most of them are blurried. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: No Reviewer #3: No |
| Formally Accepted |
|
PONE-D-20-40795R1 Impact of different frequencies of controlled breath and pressure-support levels during biphasic positive airway pressure ventilation on the lung and diaphragm in experimental mild acute respiratory distress syndrome Dear Dr. Rocco: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Andrea Coppadoro Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .